Pivotal Bio Venture Partners Investment Advisor LLC Inozyme Pharma, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $127 Million
- Q3 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 4,494,851 shares of INZY stock, worth $13.5 Million. This represents 18.53% of its overall portfolio holdings.
Number of Shares
4,494,851
Previous 4,494,851
-0.0%
Holding current value
$13.5 Million
Previous $20 Million
17.26%
% of portfolio
18.53%
Previous 18.06%
Shares
5 transactions
Others Institutions Holding INZY
# of Institutions
90Shares Held
53MCall Options Held
3.7KPut Options Held
5.8K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.67MShares$17.1 Million0.05% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$12.9 Million2.12% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.13MShares$12.4 Million0.38% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.8MShares$11.4 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$10.1 Million0.0% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $121M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...